Integra LifeSciences IART Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$4.62M+81.7% | -$1.7M— | -$5.4M+49.5% | -$484.07M-3,803% | -$25.29M-671% | ||
| $38.43M+3.3% | $38.43M+2.2% | $38.52M+7.1% | $37.69M+2.5% | $37.19M+21.7% | ||
| $5.17M+176% | $5.84M-18.4% | $5.58M+27.3% | $5.3M-26.9% | $1.87M-66.6% | ||
| $1.33M+172% | -$10.95M-56.7% | -$8.65M+4.3% | -$44.83M-2,331% | -$1.83M+35.9% | ||
| -$90K+81.8% | —— | —— | —— | -$495K-4,025% | ||
| -$13.65M+36.4% | $16.45M— | -$22.51M+21.7% | $27.99M— | -$21.45M-27.5% | ||
| $4.33M-68.4% | $3.34M+486% | $23.35M+127% | $6.38M— | $13.7M-28.0% | ||
| -$19.19M-6.6% | $23.02M+529% | $5.78M-15.3% | $15.92M— | -$18M+6.3% | ||
| $21.88M+24.6% | —— | —— | $3.67M-74.0% | $17.55M+556% | ||
| $369K-73.4% | -$21.46M-1,402% | $1.76M-76.1% | $1.16M+115% | $1.39M-26.5% | ||
| -$630K-358% | $685K-60.1% | $371K— | $2.1M-42.7% | $244K+116% | ||
| -$1.29M-698% | -$6.69M-22.2% | -$14.44M-580% | -$41K-103% | -$162K-136% | ||
| $9.8M+187% | $11.82M-76.7% | $40.91M+81.9% | $8.92M-77.9% | -$11.26M-171% | ||
| $14.85M-48.7% | $17.21M-41.8% | $15.16M-48.9% | $20.15M-32.2% | $28.92M+87.0% | ||
| $0-100% | —— | —— | $1.5M-85.7% | $7M-81.8% | ||
| -$14.85M+58.7% | -$34.91M-722% | -$15.59M-49.9% | -$21.65M+93.3% | -$35.92M+33.4% | ||
| $1.38M-35.6% | $137K+0.7% | $199K+16.4% | $225K+178% | $2.14M-31.6% | ||
| $0-100% | —— | —— | $13.85M+16.2% | $2.6M— | ||
| $8.3M-76.5% | $24.34M— | —— | —— | $35.38M-90.1% | ||
| -$1.49M-133% | $1.61M+120% | $0-100% | $12.68M+1,227% | $4.53M+191% | ||
| $1.76M+124% | —— | —— | -$21.19M+94.4% | -$7.27M-102% | ||
| $995K-28.2% | $1.02M-27.5% | $1.32M-1.5% | $1.89M+29.5% | $1.39M-0.9% | ||
| -$1.29M-698% | -$6.69M-22.2% | -$14.44M-580% | -$41K-103% | -$162K-136% | ||
| $369K-73.4% | -$21.46M-1,402% | $1.76M-76.1% | $1.16M+115% | $1.39M-26.5% | ||
| -$1.39M+8.3% | -$8K-101% | -$1M-109% | -$824K+91.0% | -$1.51M-345% | ||
| $21.88M+24.6% | —— | —— | $3.67M-74.0% | $17.55M+556% | ||
| —— | $324.75K-84.6% | $324.75K-84.6% | $324.75K-84.6% | $324.75K-84.6% | ||
| $330K+230% | —— | —— | —— | -$254K— | ||
| $38.43M+3.3% | $38.43M+2.2% | $38.52M+7.1% | $37.69M+2.5% | $37.19M+21.7% | ||
| $760K-20.6% | —— | —— | —— | $957K— | ||
| $35.59M+133% | $25.09M-37.2% | $38.69M-6.9% | $15.89M-82.5% | $15.24M+1.0% | ||
| -$630K-358% | $685K-60.1% | $371K— | $2.1M-42.7% | $244K+116% | ||
| $0-100% | —— | —— | $13.85M+16.2% | $2.6M— | ||
| $44.5M-18.2% | $49.7M+40.4% | $603.7M+2,669% | $12.9M-78.1% | $54.4M-85.3% | ||
| -$5.05M+87.4% | -$5.4M-126% | —— | -$11.23M-205% | -$40.18M-13,907% | ||
| -$5.05M+87.4% | -$5.4M-126% | —— | -$11.23M-205% | -$40.18M-13,907% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Integra LifeSciences generate?
- Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
- What is Integra LifeSciences's free cash flow?
- After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
- Where does Integra LifeSciences's cash flow data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
